22 January 2018 by Hua Luo

The specialty of pulmonary vascular medicine in China: Historical development and future directions

Over the past 40 years, Chinese experts have made great progress on research, diagnosis, and therapy of pulmonary vascular disease, including pulmonary embolism and pulmonary hypertension.

These theoretical and clinical advances have increased public awareness about this group of conditions, which are associated with significant morbidity and mortality in China and worldwide. With its theoretical basis combining knowledge from cardiovascular and pulmonary medicine, pulmonary vascular disease has developed into a separate, unique specialty in hospitals across China and worldwide.

This article will provide a short historical perspective but also an outlook into the future of this exciting novel discipline. We provide a Chinese perspective, based on our research and clinic experience over the past decades.



Specialty development, pulmonary vascular disease, pulmonary embolism, pulmonary hypertension.

Key Contributors

Hua Luo, Jingwen Li Shenzhen Hospital of Peking University, Department of Critical Care Medicine, Shenzhen, China Corresponding Author: Hua Luo, MD Shenzhen Hospital of Peking University, Intensive Care Unit, NO1120, Lianhua Road, Futian District, Shenzhen, China. Email: luoxiaoer@hotmail.com

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI